|
JPS63313723A
(ja)
|
1987-06-16 |
1988-12-21 |
Nitto Electric Ind Co Ltd |
外用貼付剤
|
|
US5656286A
(en)
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
|
JP4988080B2
(ja)
*
|
1997-09-05 |
2012-08-01 |
日東電工株式会社 |
経皮吸収型製剤
|
|
IL135258A0
(en)
|
1997-09-26 |
2001-05-20 |
Noven Pharma |
Bioadhesive compositions and methods for topical administration of active agents
|
|
WO2002024157A2
(en)
*
|
2000-09-19 |
2002-03-28 |
National Starch And Chemical Investment Holding Corporation |
Acryl adhesive useful in transdermal drug delivery systems
|
|
GB2410947B
(en)
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
|
TW200628175A
(en)
|
2004-10-08 |
2006-08-16 |
Noven Pharma |
Transdermal drug delivert device including an occlusive backing
|
|
WO2006053067A2
(en)
|
2004-11-09 |
2006-05-18 |
Prestwick Pharmaceuticals, Inc. |
Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders
|
|
GB0514501D0
(en)
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
GB2462611A
(en)
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
|
US20120208773A1
(en)
*
|
2008-08-12 |
2012-08-16 |
Valeant International (Barbados) Srl |
Pharmaceutical compositions with tetrabenazine
|
|
WO2010044981A2
(en)
|
2008-09-18 |
2010-04-22 |
Auspex Pharmaceutical ,Inc. |
Benzoquinoline inhibitors of vesicular monoamine transporter 2
|
|
CA2771539A1
(en)
|
2009-08-12 |
2011-02-17 |
Valeant International (Barbados) Srl |
Pharmaceutical compositions with tetrabenzine
|
|
DE102010024105A1
(de)
|
2010-06-17 |
2011-12-22 |
Grünenthal GmbH |
Transdermale Verabreichung von Memantin
|
|
HK1206297A1
(en)
|
2012-04-04 |
2016-01-08 |
Teva Pharmaceuticals International Gmbh |
Pharmaceutical compositions for combination therapy
|
|
EP2872126B1
(en)
*
|
2012-07-16 |
2017-12-06 |
Grünenthal GmbH |
Pharmaceutical patch for transdermal administration of tapentadol
|
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
|
WO2014195352A1
(en)
|
2013-06-04 |
2014-12-11 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal delivery system
|
|
EA201691512A1
(ru)
|
2014-01-27 |
2017-01-30 |
Оспекс Фармасьютикалз, Инк. |
Бензохинолиновые ингибиторы везикулярного переносчика моноамина 2
|
|
NZ760790A
(en)
|
2014-02-07 |
2022-11-25 |
Neurocrine Biosciences Inc |
Pharmaceutical compositions comprising an antipsychotic drug and a vmat2 inhibitor and uses thereof
|
|
WO2015171802A1
(en)
*
|
2014-05-06 |
2015-11-12 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitors for the treatment of hyperkinetic movement disorders
|
|
AR098771A1
(es)
*
|
2014-12-16 |
2016-06-15 |
Amarin Tech S A |
Un dispositivo para la administración transdérmica de rotigotina
|
|
HRP20221106T1
(hr)
|
2015-03-06 |
2022-11-25 |
Auspex Pharmaceuticals, Inc. |
Postupci liječenja abnormalnih nevoljnih poremećaja pokreta
|
|
EA036837B1
(ru)
|
2015-06-23 |
2020-12-25 |
Нейрокрин Байосайенсиз, Инк. |
Ингибиторы vmat2 для лечения неврологических заболеваний или расстройств
|
|
US11191734B2
(en)
|
2015-06-27 |
2021-12-07 |
Shenox Pharmaceuticals, Llc |
Ketamine transdermal delivery system
|
|
CN107028916B
(zh)
*
|
2016-02-04 |
2020-05-12 |
北京泰德制药股份有限公司 |
含有布比卡因或其药用盐的皮肤外用制剂
|
|
ITUB20161016A1
(it)
*
|
2016-02-24 |
2017-08-24 |
Emenem Srl |
Composizioni farmaceutiche o cosmetiche comprendenti un polimero e un promotore di assorbimento per il rilascio controllato di principi attivi
|
|
ES2769286T3
(es)
|
2016-12-20 |
2020-06-25 |
Lts Lohmann Therapie Systeme Ag |
Sistema terapéutico transdérmico que contiene asenapina
|
|
WO2018140092A1
(en)
|
2017-01-27 |
2018-08-02 |
Obrien Christopher F |
Methods for the administration of certain vmat2 inhibitors
|
|
CN110678181A
(zh)
|
2017-04-01 |
2020-01-10 |
阿德普蒂奥制药有限公司 |
(+)-α-二氢丁苯那嗪在治疗运动障碍中的用途
|
|
US20190111035A1
(en)
|
2017-04-01 |
2019-04-18 |
Adeptio Pharmaceuticals Limited |
Pharmaceutical compositions
|
|
GB201705304D0
(en)
|
2017-04-01 |
2017-05-17 |
Adeptio Pharmaceuticals Ltd |
Pharmaceutical compositions
|
|
WO2018200605A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
|
TWI741168B
(zh)
*
|
2017-04-28 |
2021-10-01 |
日商日東電工股份有限公司 |
經皮吸收製劑
|
|
WO2019016357A1
(en)
|
2017-07-20 |
2019-01-24 |
Neurolixis |
USE OF SELECTIVE 5-HT1A SEROTONIN RECEPTOR AGONISTS TO TREAT THE ADVERSE EFFECTS OF VMAT INHIBITORS
|
|
GB2565049B
(en)
|
2017-07-27 |
2020-06-10 |
Reckitt Benckiser Health Ltd |
A head assembly of a dermaplaning device
|
|
JP2021502959A
(ja)
|
2017-10-10 |
2021-02-04 |
ニューロクライン バイオサイエンシーズ，インコーポレイテッド |
特定のｖｍａｔ２インヒビターを投与するための方法
|
|
EP3784237B1
(en)
|
2018-04-25 |
2023-11-01 |
Shinkei Therapeutics, Inc. |
Tetrabenazine transdermal delivery device
|
|
US20190374521A1
(en)
|
2018-06-10 |
2019-12-12 |
Axsome Therapeutics, Inc. |
Methods of modulating tetrabenazine metabolites plasma levels using bupropion
|
|
MX2020013004A
(es)
|
2018-06-14 |
2021-02-17 |
Neurocrine Biosciences Inc |
Compuestos inhibidores del transportador de monoamina 2 (vmat2), composiciones, y metodos relacionados con los mismos.
|